Aseptic meningitis: Case definition and guidelines for collection, analysis and presentation of immunization safety data

Vaccine

Volumn 25, Issue 31, 2007, Pages 5793-5802

  Tapiainen, Terhi ^a,b   Prevots, Rebecca ^c   Izurieta, Hector S ^d   Abramson, Jon ^e   Bilynsky, Roman ^f   Bonhoeffer, Jan ^a   Bonnet, Marie Claude ^g   Center, Kimberly ^h   Galama, Jochem ⁱ   Gillard, Paul ^j   Griot, Monika ^k   Hartmann, Katharina ^k   Heininger, Ulrich ^a   Hudson, Michael ^l   Koller, Annette ^k   Khetsuriani, Nino ^m   Khuri Bulos, Najwa ⁿ   Marcy, S Michael ^o   Matulionyte, Raimonda ^p   Schöndorf, Ines ^q   Sejvar, James ^m   Steele, Russell ^r   more..

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF OULU   (Finland)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f Patterson Army Health Center   (United States)

^g SANOFI PASTEUR   (France)

^h PFIZER INC   (United States)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j GSK   (Belgium)

^k Berna Biotech ^*  (Switzerland)

^l PUBLIC HEALTH ENGLAND   (United Kingdom)

^m CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁿ JORDAN UNIVERSITY HOSPITAL   (Jordan)

^o UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^p VILNIUS UNIVERSITY   (Lithuania)

^q Novartis Vaccine   (Germany)

^r LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Adverse event; Aseptic meningitis; Case definition; Guidelines; Immunization

Indexed keywords

LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; ORAL POLIOMYELITIS VACCINE; SMALLPOX VACCINE; VACCINE; VIRUS VACCINE;

ARTICLE; ASEPTIC MENINGITIS; CASE DEFINITION; CASE STUDY; CEREBROSPINAL FLUID EXAMINATION; CLINICAL PRACTICE; CLINICAL RESEARCH; DATA ANALYSIS; DRUG SAFETY; HUMAN; IMMUNIZATION; LEUKOCYTE COUNT; LEUKOCYTOSIS; LUMBAR PUNCTURE; MEASLES; MUMPS; POLIOMYELITIS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RUBELLA; SMALLPOX; STANDARD; VIRUS CULTURE; VIRUS INFECTION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; HUMANS; IMMUNIZATION; MEASLES-MUMPS-RUBELLA VACCINE; MENINGITIS, ASEPTIC; SAFETY; SMALLPOX VACCINE; TERMINOLOGY;

EID: 34447257189     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.058     Document Type: Article

References (75)

1. Cherry JD, Nielsen KA. Aseptic meningitis and viral meningitis. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL, editors. Textbook of pediatric infectious diseases, vol. 2. Philadelphia: W.B. Saunders; 2004, p. 497-505.
2. Centers for Disease Control and Prevention Division of Public Health Surveillance and Informatics. Aseptic meningitis 1990 case definition [web page]. Available at http://www.cdc.gov/epo/dphsi/casedef/asmeningitiscurrent.htm.
3. Bottner A., Daneschnejad S., Handrick W., Schuster V., Liebert U.G., and Kiess W. A season of aseptic meningitis in Germany: epidemiologic, clinical and diagnostic aspects. Pediatr Infect Dis J 21 12 (2002) 1126-1132
4. Ramers C., Billman G., Hartin M., Ho S., and Sawyer M.H. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 283 20 (2000) 2680-2685
5. Huang C., Morse D., Slater B., Anand M., Tobin E., Smith P., et al. Multiple-year experience in the diagnosis of viral central nervous system infections with a panel of polymerase chain reaction assays for detection of 11 viruses. Clin Infect Dis 39 5 (2004) 630-635
6. Silber E., Sonnenberg P., Ho K.C., Koornhof H.J., Eintracht S., Morris L., et al. Meningitis in a community with a high prevalence of tuberculosis and HIV infection. J Neurol Sci 162 1 (1999) 20-26
7. Gerber M.A., Shapiro E.D., Burke G.S., Parcells V.J., and Bell G.L. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 335 17 (1996) 1270-1274
8. Romero E.C., Billerbeck A.E., Lando V.S., Camargo E.D., Souza C.C., and Yasuda P.H. Detection of Leptospira DNA in patients with aseptic meningitis by PCR. J Clin Microbiol 36 5 (1998) 1453-1455
9. Cano-Sanchez A., Cano-Gracia H., Fernandez-Pardo J., Artero-Galan J.M., and Gonzalez-Sicilia L. Aseptic meningitis caused by Mycoplasma pneumoniae in a 19-year-old woman. Eur J Clin Microbiol Infect Dis 18 3 (1999) 228-229
10. Golden S.E. Aseptic meningitis associated with Ehrlichia canis infection. Pediatr Infect Dis J 8 5 (1989) 335-337
11. Hoffman M.A., Valderrama E., Fuchs A., Friedman M., and Rai K. Leukemic meningitis in B-cell prolymphocytic leukemia: a clinical, pathologic, and ultrastructural case study and a review of the literature. Cancer 75 5 (1995) 1100-1103
12. Redman IV R.C., Miller J.B., Hood M., and DeMaio J. Trimethoprim-induced aseptic meningitis in an adolescent male. Pediatrics 110 2 Pt 1 (2002) e26
13. Beghi E., Nicolosi A., Kurland L.T., Mulder D.W., Hauser W.A., and Shuster L. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981. I. Epidemiology. Ann Neurol 16 3 (1984) 283-294
14. Gutierrez K., and Abzug M.J. Vaccine-associated poliovirus meningitis in children with ventriculoperitoneal shunts. J Pediatr 117 3 (1990) 424-427
15. Monath T.P. Yellow fever vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), W.B. Saunders, Philadelphia
16. Henderson D.A., Borio L.L., and Lane J.M. Smallpox and vaccinia. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), W.B. Saunders, Philadelphia
17. Bahri F., Letaief A., Ernez M., Elouni J., Chekir T., Ben Ammou S., et al. Neurological complications in adults following rabies vaccine prepared from animal brains. Presse Med 25 10 (1996) 491-493
18. Dourado I., Cunha S., Teixeira M.G., Farrington C.P., Melo A., Lucena R., et al. Outbreak of aseptic meningitis associated with mass vaccination with a Urabe-containing measles-mumps-rubella vaccine: implications for immunization programs. Am J Epidemiol 151 5 (2000) 524-533
19. Farrington P., Pugh S., Colville A., Flower A., Nash J., Morgan-Capner P., et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 345 8949 (1995) 567-569
20. da Silveira C.M., Kmetzsch C.I., Mohrdieck R., Sperb A.F., and Prevots D.R. The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997 [comment]. Int J Epidemiol 31 5 (2002) 978-982
21. Ki M., Park T., Yi S.G., Oh J.K., and Choi B. Risk analysis of aseptic meningitis after measles-mumps-rubella vaccination in Korean children by using a case-crossover design. Am J Epidemiol 157 2 (2003) 158-165
22. Black S., Shinefield H., Ray P., Lewis E., Chen R., Glasser J., et al. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project. Pediatr Infect Dis J 16 5 (1997) 500-503
23. Mäkelä A., Nuorti J.P., and Peltola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 110 5 (2002) 957-963
24. Maksimova O.A., Popov V.F., Bektimirov T.A., Grigoreva L.V., Iunasova TNKOP, and Sharova O.K. Comparative evaluation of neurovirulence of domestic and foreign live mumps vaccine. Vopr Virusol 46 (2001) 31-35
25. Cizman M., Mozetic M., Radescek-Rakar R., Pleterski-Rigler D., and Susec-Michieli M. Aseptic meningitis after vaccination against measles and mumps. Pediatr Infect Dis J 8 5 (1989) 302-308
26. Patja A., Davidkin I., Kurki T., Kallio M.J., Valle M., and Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a 14-year prospective follow-up. Pediatr Infect Dis J 19 12 (2000) 1127-1134
27. Kraigher A. Monitoring side-effects and adverse events following immunization against measles and mumps in a national vaccination programme in Slovenia 1982-1985. Dissertation. Zagreb, Croatia: Medical Faculty; 1990 [in Slovenian].
28. Souza da Cunha S., Rodrigues L.C., Barreto M.L., and Dourado I. Outbreak of aseptic meningitis and mumps after mass vaccination campaign with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine 20 (2002) 1106-1112
29. Sugiura A., and Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 10 3 (1991) 209-213
30. Jonville-Bera A.P., Autret E., Galy-Eyraud C., and Hessel L. Aseptic meningitis following mumps vaccine. A retrospective survey by the French Regional Pharmacovigilance Centres and by Pasteur-Merieux Serums and Vaccins. Pharmacoepidemiol Drug Saf 5 1 (1996) 33-37
31. Bino S., Kakarriqi E., Xibinaku M., Ion-Nedelcu N., Bukli M., Emiroglu N., et al. Measles-rubella mass immunization campaign in Albania, November 2000. J Infect Dis 187 Suppl. 1 (2003) S223-S229
32. Lucena R., Gomes I., Nunes L., Cunha S., Dourado I., Teixeira Mda G., et al. Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine. Rev Panam Salud Publ 12 4 (2002) 258-261
33. Miller E., Goldacre M., Pugh S., Colville A., Farrington P., Flower A., et al. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet 341 8851 (1993) 979-982
34. Schlipkoter U., Muhlberger N., Von Kries R., and Weil J. Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany. Infection 30 6 (2002) 351-355
35. Al-Mazrou Y., Tumsah S., Khalil M., Al-Jeffri M., Afzal M.A., al-Ghamdy Y., et al. Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia. J Trop Pediatr 48 6 (2002) 354-358
36. Tesovic G., Begovac J., and Bace A. Aseptic meningitis after measles, mumps, and rubella vaccine [comment]. Lancet 341 8859 (1993) 1541
37. Kirschke D.L., Jones T.F., Buckingham S.C., Craig A.S., and Schaffner W. Outbreak of aseptic meningitis associated with echovirus 13. Pediatr Infect Dis J 21 11 (2002) 1034-1038
38. Elmore J.G., Horwitz R.I., and Quagliarello V.J. Acute meningitis with a negative Gram's stain: clinical and management outcomes in 171 episodes. Am J Med 100 1 (1996) 78-84
39. Eppes S.C., Nelson D.K., Lewis L.L., and Klein J.D. Characterization of Lyme meningitis and comparison with viral meningitis in children. Pediatrics 103 5 Pt 1 (1999) 957-960
40. Rorabaugh M.L., Berlin L.E., Heldrich F., Roberts K., Rosenberg L.A., Doran T., et al. Aseptic meningitis in infants younger than 2 years of age: acute illness and neurologic complications. Pediatrics 92 2 (1993) 206-211
41. Widell S. On the cerebrospinal fluid in normal children and in patients with acute abacterial meningo-encephalitis. Acta Paediatr 47 Suppl. 115 (1958) 1-102
42. Sornas R. The cytology of the normal cerebrospinal fluid. Acta Neurol Scand 48 3 (1972) 313-320
43. Svenningsson A., Andersen O., Edsbagge M., and Stemme S. Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J Neuroimmunol 63 1 (1995) 39-46
44. Davis L.E. Normal laboratory values of CSF during pregnancy. Arch Neurol 36 7 (1979) 443
45. Ahmed A., Hickey S.M., Ehrett S., Trujillo M., Brito F., Goto C., et al. Cerebrospinal fluid values in the term neonate. Pediatr Infect Dis J 15 4 (1996) 298-303
46. Carraccio C., Blotny K., and Fisher M.C. Cerebrospinal fluid analysis in systemically ill children without central nervous system disease. Pediatrics 96 1 Pt 1 (1995) 48-51
47. Bonadio W.A., Stanco L., Bruce R., Barry D., and Smith D. Reference values of normal cerebrospinal fluid composition in infants ages 0-8 weeks. Pediatr Infect Dis J 11 7 (1992) 589-591
48. Feigin RD, Cherry JD, Demmler GJ, Kaplan SL. Textbook of pediatric infectious diseases, vol. 2. Philadelphia: W.B. Saunders; 2004, p. 1893, 2010, 2309.
49. Tunkel A.R., Hartman B.J., Kaplan S.L., Kaufman B.A., Roos K.L., Scheld W.M., et al. Practice guidelines for the management of bacterial meningitis. Clin Inf Dis 39 (2004) 1267-1284
50. Donald P.R., Schoeman J.F., Cotton M.F., and van Zyl L.E. Cerebrospinal fluid investigations in tuberculous meningitis. Ann Trop Paediatr 11 3 (1991) 241-246
51. Sormunen P., Kallio M.J., Kilpi T., and Peltola H. C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr 134 6 (1999) 725-729
52. Abramson J.S., Hampton K.D., Babu S., Wasilauskas B.L., and Marcon M.J. The use of C-reactive protein from cerebrospinal fluid for differentiating meningitis from other central nervous system diseases. J Infect Dis 151 5 (1985) 854-858
53. Wong M., Schlaggar B.L., and Landt M. Postictal cerebrospinal fluid abnormalities in children. J Pediatr 138 3 (2001) 373-377
54. Negrini B., Kelleher K.J., and Wald E. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 105 2 (2000) 316-319
55. Sejvar J.J., Kohl K.S., Bilynsky R., Blumberg D., Cvetkovich T., Galama J., et al. Encephalitis as an adverse event following immunization (AEFI) case definition and guidelines for data collection, analysis and presentation. Vaccine 25 (2007) 5771-5792
56. Mazor S.S., McNulty J.E., and Roosevelt G.E. Interpretation of traumatic lumbar punctures: who can go home?. Pediatrics 111 3 (2003) 525-528
57. Kaplan S.L., Smith E.O., Wills C., and Feigin R.D. Association between preadmission oral antibiotic therapy and cerebrospinal fluid findings and sequelae caused by Haemophilus influenzae type b meningitis. Pediatr Infect Dis 5 6 (1986) 626-632
58. Kanegaye J.T., Soliemanzadeh P., and Bradley J.S. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 108 5 (2001) 1169-1174
59. Gray L.D., and Fedorko D.P. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev 5 (1992) 130-145
60. Tarafdar K., Rao S., Recco R.A., and Zaman M.M. Lack of sensitivity of the latex agglutination test to detect bacterial antigen in the cerebrospinal fluid of patients with culture-negative meningitis. Clin Infect Dis 33 3 (2001) 406-408
61. Nigrovic L.E., Kuppermann N., McAdam A.J., and Malley R. Cerebrospinal latex agglutination fails to contribute to the microbiologic diagnosis of pretreated children with meningitis. Pediatr Infect Dis J 23 8 (2004) 786-788
62. Cohen B.J., Jin L., Brown D.W., and Kitson M. Infection with wild-type mumps virus in army recruits temporally associated with MMR vaccine. Epidemiol Infect 123 2 (1999) 251-255
63. Bitnun A., Shannon P., Durward A., Rota P.A., Bellini W.J., Graham C., et al. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis 29 4 (1999) 855-861
64. Kew O., Morris-Glasgow V., Landaverde M., Burns C., Shaw J., Garib Z., et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296 5566 (2002) 356-359
65. Boot H.J., Schepp R.M., van Nunen F.J., and Kimman T.G. Rapid RT-PCR amplification of full-length poliovirus genomes allows rapid discrimination between wild-type and recombinant vaccine-derived polioviruses. J Virol Methods 116 1 (2004) 35-43
66. Martin J., Ferguson G.L., Wood D.J., and Minor P.D. The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland. Virology 278 1 (2000) 42-49
67. Cherkasova E.A., Korotkova E.A., Yakovenko M.L., Ivanova O.E., Eremeeva T.P., Chumakov K.M., et al. Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J Virol 76 13 (2002) 6791-6799
68. Chibo D., Riddell M., Catton M., Lyon M., Lum G., and Birch C. Studies of measles viruses circulating in Australia between 1999 and 2001 reveals a new genotype. Virus Res 91 2 (2003) 213-221
69. Kashiwagi Y., Kawashima H., Takekuma K., Hoshika A., Mori T., and Nakayama T. Detection of mumps virus genome directly from clinical samples and a simple method for genetic differentiation of the Hoshino vaccine strain from wild strains of mumps virus. J Med Virol 52 2 (1997) 195-199
70. Damaso C.R., Esposito J.J., Condit R.C., and Moussatche N. An emergent poxvirus from humans and cattle in Rio de Janeiro State: Cantagalo virus may derive from Brazilian smallpox vaccine. Virology 277 2 (2000) 439-449
71. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for clinical safety assessment (E2a-e). [Available on the world wide web: http://www.ich.org/; last accessed on August 18, 2006].
72. Council for International Organizations of Medical Sciences (CIOMS). Reporting form for international reporting of adverse drug reactions. [Available on the world wide web: http://www.cioms.ch/frame_what_is_cioms.htm; last accessed on August 18, 2006].
73. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285 15 (2001) 1987-1991. http://www.consort-statement.org/Statement/revisedstatement.htm [Available on the world wide web: http://www.consort-statement.org/Statement/revisedstatement.htm; last accessed on August 18, 2006]
74. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354 9193 (1999) 1896-1900. http://www.consort-statement.org/Initiatives/complements.htm [Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm; last accessed on August 18, 2006]
75. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283 15 (2000) 2008-2012. http://www.consort-statement.org/Initiatives/complements.htm [Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm; last accessed on August 18, 2006]